{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:54Z","timestamp":1792025214806,"version":"4.4.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130056"],"award-info":[{"award-number":["82130056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07185-7","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:07:51Z","timestamp":1792022871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the addictive potential of \u03b1-methylfentanyl and acetyl-\u03b1-methylfentanyl in animal models"],"prefix":"10.1007","author":[{"given":"Deli","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Kuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"7185_CR1","doi-asserted-by":"publisher","unstructured":"Asinof SK, Paine TA (2014) The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents. J Vis Exp 51574. https:\/\/doi.org\/10.3791\/51574","DOI":"10.3791\/51574"},{"key":"7185_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.bbr.2016.06.061","volume":"312","author":"N Assar","year":"2016","unstructured":"Assar N, Mahmoudi D, Farhoudian A et al (2016) D1- and D2-like dopamine receptors in the CA1 region of the hippocampus are involved in the acquisition and reinstatement of morphine-induced conditioned place preference. Behav Brain Res 312:394\u2013404. https:\/\/doi.org\/10.1016\/j.bbr.2016.06.061","journal-title":"Behav Brain Res"},{"key":"7185_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrn3104","volume":"12","author":"A Badiani","year":"2011","unstructured":"Badiani A, Belin D, Epstein D et al (2011) Opiate versus psychostimulant addiction: the differences do matter. Nat Rev Neurosci 12:685\u2013700. https:\/\/doi.org\/10.1038\/nrn3104","journal-title":"Nat Rev Neurosci"},{"key":"7185_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1529100619860513","volume":"20","author":"A Bechara","year":"2019","unstructured":"Bechara A, Berridge KC, Bickel WK et al (2019) A Neurobehavioral Approach to Addiction: Implications for the Opioid Epidemic and the Psychology of Addiction. Psychol Sci Public Interest 20:96\u2013127. https:\/\/doi.org\/10.1177\/1529100619860513","journal-title":"Psychol Sci Public Interest"},{"key":"7185_CR5","doi-asserted-by":"publisher","first-page":"105618","DOI":"10.1016\/j.neubiorev.2024.105618","volume":"160","author":"CL Bergeria","year":"2024","unstructured":"Bergeria CL, Gipson CD, Smith KE et al (2024) Opioid craving does not incubate over time in inpatient or outpatient treatment studies: is the preclinical incubation of craving model lost in translation? Neurosci Biobehav Rev 160:105618. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105618","journal-title":"Neurosci Biobehav Rev"},{"key":"7185_CR6","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/0024-3205(90)90178-T","volume":"47","author":"WK Bickel","year":"1990","unstructured":"Bickel WK, DeGrandpre RJ, Higgins ST, Hughes JR (1990) Behavioral economics of drug self-administration. I. Functional equivalence of response requirement and drug dose. Life Sci 47:1501\u20131510. https:\/\/doi.org\/10.1016\/0024-3205(90)90178-T","journal-title":"Life Sci"},{"key":"7185_CR67","doi-asserted-by":"publisher","unstructured":"Bolin BL, Alcorn JL, Reynolds AR, et al (2016) Human drug discrimination: A primer and methodological review. Exp Clin Psychopharmacol 24:214\u2013228. https:\/\/doi.org\/10.1037\/pha0000077","DOI":"10.1037\/pha0000077"},{"key":"7185_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.biopsych.2020.02.014","volume":"88","author":"JM Bossert","year":"2020","unstructured":"Bossert JM, Kiyatkin EA, Korah H et al (2020) In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia. Biol Psychiatry 88:935\u2013944. https:\/\/doi.org\/10.1016\/j.biopsych.2020.02.014","journal-title":"Biol Psychiatry"},{"key":"7185_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-024-07440-x","volume":"630","author":"F Chaudun","year":"2024","unstructured":"Chaudun F, Python L, Liu Y et al (2024) Distinct \u00b5-opioid ensembles trigger positive and negative fentanyl reinforcement. Nature 630:141\u2013148. https:\/\/doi.org\/10.1038\/s41586-024-07440-x","journal-title":"Nature"},{"key":"7185_CR9","doi-asserted-by":"publisher","first-page":"106888","DOI":"10.1016\/j.ejps.2024.106888","volume":"202","author":"J Chen","year":"2024","unstructured":"Chen J, Li Y, Wang F et al (2024) Fentanyl induces analgesic effect through miR-381-3p\/TRPM7 when combined with bupivacaine in subarachnoid injection. Eur J Pharm Sci 202:106888. https:\/\/doi.org\/10.1016\/j.ejps.2024.106888","journal-title":"Eur J Pharm Sci"},{"key":"7185_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D (2021) The Rise of Illicit Fentanyls, Stimulants and the Fourth Wave of the Opioid Overdose Crisis. Curr Opin Psychiatry 34:344\u2013350. https:\/\/doi.org\/10.1097\/YCO.0000000000000717","journal-title":"Curr Opin Psychiatry"},{"key":"7185_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","volume":"106","author":"SD Comer","year":"2019","unstructured":"Comer SD, Cahill CM (2019) Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment. Neurosci Biobehavioral Reviews 106:49\u201357. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.12.005","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"7185_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.conb.2004.05.005","volume":"14","author":"C Contet","year":"2004","unstructured":"Contet C, Kieffer BL, Befort K (2004) Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 14:370\u2013378. https:\/\/doi.org\/10.1016\/j.conb.2004.05.005","journal-title":"Curr Opin Neurobiol"},{"key":"7185_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","volume":"19","author":"E Darcq","year":"2018","unstructured":"Darcq E, Kieffer BL (2018) Opioid receptors: drivers to addiction? Nat Rev Neurosci 19:499\u2013514. https:\/\/doi.org\/10.1038\/s41583-018-0028-x","journal-title":"Nat Rev Neurosci"},{"key":"7185_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41386-021-01159-3","volume":"47","author":"A Durand","year":"2022","unstructured":"Durand A, Girardeau P, Freese L, Ahmed SH (2022) Increased responsiveness to punishment of cocaine self-administration after experience with high punishment. Neuropsychopharmacol 47:444\u2013453. https:\/\/doi.org\/10.1038\/s41386-021-01159-3","journal-title":"Neuropsychopharmacol"},{"key":"7185_CR15","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","volume":"43","author":"BM Gannon","year":"2018","unstructured":"Gannon BM, Baumann MH, Walther D et al (2018) The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter. Neuropsychopharmacology 43:2399\u20132407. https:\/\/doi.org\/10.1038\/s41386-018-0209-3","journal-title":"Neuropsychopharmacology"},{"key":"7185_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.euroneuro.2003.08.003","volume":"13","author":"MAFM Gerrits","year":"2003","unstructured":"Gerrits MAFM, Lesscher HBM, Van Ree JM (2003) Drug dependence and the endogenous opioid system. Eur Neuropsychopharmacol 13:424\u2013434. https:\/\/doi.org\/10.1016\/j.euroneuro.2003.08.003","journal-title":"Eur Neuropsychopharmacol"},{"key":"7185_CR17","doi-asserted-by":"publisher","first-page":"eaaz3140","DOI":"10.1126\/scisignal.aaz3140","volume":"13","author":"A Gillis","year":"2020","unstructured":"Gillis A, Gondin AB, Kliewer A et al (2020) Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Sci Signal 13:eaaz3140. https:\/\/doi.org\/10.1126\/scisignal.aaz3140","journal-title":"Sci Signal"},{"key":"7185_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41380-023-02371-x","volume":"29","author":"X Guo","year":"2024","unstructured":"Guo X, Yuan Y, Su X et al (2024) Different projection neurons of basolateral amygdala participate in the retrieval of morphine withdrawal memory with diverse molecular pathways. Mol Psychiatry 29:793\u2013808. https:\/\/doi.org\/10.1038\/s41380-023-02371-x","journal-title":"Mol Psychiatry"},{"key":"7185_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41398-019-0625-0","volume":"9","author":"Y Han","year":"2019","unstructured":"Han Y, Yan W, Zheng Y et al (2019) The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. Transl Psychiatry 9:282. https:\/\/doi.org\/10.1038\/s41398-019-0625-0","journal-title":"Transl Psychiatry"},{"key":"7185_CR19","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s12264-022-00872-3","volume":"38","author":"Y Han","year":"2022","unstructured":"Han Y, Cao L, Yuan K et al (2022) Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse. Neurosci Bull 38:1365\u20131382. https:\/\/doi.org\/10.1007\/s12264-022-00872-3","journal-title":"Neurosci Bull"},{"key":"7185_CR21","unstructured":"Health and Human Services Department (2024) Medications for the Treatment of Opioid Use Disorder. In: Federal Register. https:\/\/www.federalregister.gov\/documents\/2024\/02\/02\/2024-01693\/medications-for-the-treatment-of-opioid-use-disorder. Accessed 24 Dec 2024"},{"key":"7185_CR22","doi-asserted-by":"crossref","unstructured":"Higashikawa Y, Suzuki S (2008) Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure\u2013analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicol","DOI":"10.1007\/s11419-007-0039-1"},{"key":"7185_CR23","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1186\/s12913-019-4751-4","volume":"19","author":"KA Hoffman","year":"2019","unstructured":"Hoffman KA, Ponce Terashima J, McCarty D (2019) Opioid use disorder and treatment: challenges and opportunities. BMC Health Serv Res 19:884. https:\/\/doi.org\/10.1186\/s12913-019-4751-4","journal-title":"BMC Health Serv Res"},{"key":"7185_CR24","doi-asserted-by":"publisher","first-page":"173848","DOI":"10.1016\/j.pbb.2024.173848","volume":"244","author":"S Huang","year":"2024","unstructured":"Huang S, Riley AL (2024) Drug discrimination learning: Interoceptive stimulus control of behavior and its implications for regulated and dysregulated drug intake. Pharmacol Biochem Behav 244:173848. https:\/\/doi.org\/10.1016\/j.pbb.2024.173848","journal-title":"Pharmacol Biochem Behav"},{"key":"7185_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1037\/0033-295X.115.1.186","volume":"115","author":"SR Hursh","year":"2008","unstructured":"Hursh SR, Silberberg A (2008) Economic demand and essential value. Psychol Rev 115:186\u2013198. https:\/\/doi.org\/10.1037\/0033-295X.115.1.186","journal-title":"Psychol Rev"},{"key":"7185_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00213-016-4492-6","volume":"234","author":"SL Huskinson","year":"2017","unstructured":"Huskinson SL, Naylor JE, Townsend EA et al (2017) Self-administration and behavioral economics of second-generation synthetic cathinones in male rats. Psychopharmacology 234:589\u2013598. https:\/\/doi.org\/10.1007\/s00213-016-4492-6","journal-title":"Psychopharmacology"},{"key":"7185_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41583-018-0092-2","volume":"20","author":"C Kibaly","year":"2019","unstructured":"Kibaly C, Xu C, Cahill CM et al (2019) Non-nociceptive roles of opioids in the CNS: opioids\u2019 effects on neurogenesis, learning, memory and affect. Nat Rev Neurosci 20:5\u201318. https:\/\/doi.org\/10.1038\/s41583-018-0092-2","journal-title":"Nat Rev Neurosci"},{"key":"7185_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biopsych.2019.05.023","volume":"87","author":"GF Koob","year":"2020","unstructured":"Koob GF (2020) Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement. Biol Psychiatry 87:44\u201353. https:\/\/doi.org\/10.1016\/j.biopsych.2019.05.023","journal-title":"Biol Psychiatry"},{"key":"7185_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3:760\u2013773. https:\/\/doi.org\/10.1016\/S2215-0366(16)00104-8","journal-title":"Lancet Psychiatry"},{"key":"7185_CR30","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1124\/dmd.118.085977","volume":"47","author":"P Krieter","year":"2019","unstructured":"Krieter P, Chiang CN, Gyaw S et al (2019) Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects. Drug Metab Dispos 47:690\u2013698. https:\/\/doi.org\/10.1124\/dmd.118.085977","journal-title":"Drug Metab Dispos"},{"key":"7185_CR31","doi-asserted-by":"publisher","unstructured":"Kuhn BN, Kalivas PW, Bobadilla A-C (2019) Understanding Addiction Using Animal Models. Front Behav Neurosci 13. https:\/\/doi.org\/10.3389\/fnbeh.2019.00262","DOI":"10.3389\/fnbeh.2019.00262"},{"key":"7185_CR32","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1007\/s00213-022-06173-x","volume":"239","author":"M Lai","year":"2022","unstructured":"Lai M, Fu D, Xu Z et al (2022) Relative reinforcing effects of dibutylone, ethylone, and N-ethylpentylone: self-administration and behavioral economics analysis in rats. Psychopharmacology 239:2875\u20132884. https:\/\/doi.org\/10.1007\/s00213-022-06173-x","journal-title":"Psychopharmacology"},{"key":"7185_CR33","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1056\/nejmoa1505409","volume":"374","author":"JD Lee","year":"2016","unstructured":"Lee JD, Friedmann PD, Kinlock TW et al (2016) Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. N Engl J Med 374:1232\u20131242. https:\/\/doi.org\/10.1056\/nejmoa1505409","journal-title":"N Engl J Med"},{"key":"7185_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41598-023-27992-8","volume":"13","author":"M Leonardo","year":"2023","unstructured":"Leonardo M, Brunty S, Huffman J et al (2023) Intravenous fentanyl self-administration in male and female C57BL\/6J and DBA\/2J mice. Sci Rep 13:799. https:\/\/doi.org\/10.1038\/s41598-023-27992-8","journal-title":"Sci Rep"},{"key":"7185_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0091-3057(91)90210-s","volume":"39","author":"P Leone","year":"1991","unstructured":"Leone P, Pocock D, Wise RA (1991) Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav 39:469\u2013472. https:\/\/doi.org\/10.1016\/0091-3057(91)90210-s","journal-title":"Pharmacol Biochem Behav"},{"key":"7185_CR36","doi-asserted-by":"publisher","first-page":"e13171","DOI":"10.1111\/adb.13171","volume":"27","author":"F Li","year":"2022","unstructured":"Li F, Du H, Wu B et al (2022a) 2-Fluorodeschloroketamine has similar abuse potential as ketamine. Addict Biol 27:e13171. https:\/\/doi.org\/10.1111\/adb.13171","journal-title":"Addict Biol"},{"key":"7185_CR37","doi-asserted-by":"publisher","first-page":"11711","DOI":"10.1038\/s41598-022-15833-z","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Qu L, Li N et al (2022b) The optimized jugular vein catheterization reinforced cocaine self-administration addictive model for adult male sprague\u2013dawley rats. Sci Rep 12:11711. https:\/\/doi.org\/10.1038\/s41598-022-15833-z","journal-title":"Sci Rep"},{"key":"7185_CR38","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41586-024-07796-0","volume":"632","author":"Y Li","year":"2024","unstructured":"Li Y, Wang X, Meng Y et al (2024) Dopamine reuptake and inhibitory mechanisms in human dopamine transporter. Nature 632:686\u2013694. https:\/\/doi.org\/10.1038\/s41586-024-07796-0","journal-title":"Nature"},{"key":"7185_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.conb.2013.02.005","volume":"23","author":"P-E Lutz","year":"2013","unstructured":"Lutz P-E, Kieffer BL (2013) The multiple facets of opioid receptor function: implications for addiction. Curr Opin Neurobiol 23:473\u2013479. https:\/\/doi.org\/10.1016\/j.conb.2013.02.005","journal-title":"Curr Opin Neurobiol"},{"key":"7185_CR40","doi-asserted-by":"publisher","first-page":"pyv030","DOI":"10.1093\/ijnp\/pyv030","volume":"18","author":"X-F Lv","year":"2015","unstructured":"Lv X-F, Sun L-L, Cui C-L, Han J-S (2015) NAc Shell Arc\/Arg3.1 Protein Mediates Reconsolidation of Morphine CPP by Increased GluR1 Cell Surface Expression: Activation of ERK-Coupled CREB is Required. IJNPPY 18:pyv030. https:\/\/doi.org\/10.1093\/ijnp\/pyv030","journal-title":"IJNPPY"},{"key":"7185_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/fbp.0000000000000502","author":"DR Maguire","year":"2020","unstructured":"Maguire DR, Minervini V, Dodda V, France CP (2020) Impact of order of fixed-ratio presentation on demand for self-administered remifentanil in male rats. Behav Pharmacol. https:\/\/doi.org\/10.1097\/fbp.0000000000000502","journal-title":"Behav Pharmacol"},{"key":"7185_CR42","doi-asserted-by":"publisher","first-page":"eadr5051","DOI":"10.1126\/sciadv.adr5051","volume":"11","author":"R Merkel","year":"2025","unstructured":"Merkel R, Hernandez NS, Weir V et al (2025) An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking. Sci Adv 11:eadr5051. https:\/\/doi.org\/10.1126\/sciadv.adr5051","journal-title":"Sci Adv"},{"key":"7185_CR43","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.celrep.2019.06.071","volume":"28","author":"M-H Nam","year":"2019","unstructured":"Nam M-H, Han K-S, Lee J et al (2019) Activation of Astrocytic \u00b5-Opioid Receptor Causes Conditioned Place Preference. Cell Rep 28:1154\u20131166e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.06.071","journal-title":"Cell Rep"},{"key":"7185_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/00000542-197605000-00008","volume":"44","author":"SH Ngai","year":"1976","unstructured":"Ngai SH, Berkowitz BA, Yang JC et al (1976) Pharmacokinetics of Naloxone in Rats and in Man: Basis for Its Potency and Short Duration of Action. Anesthesiology 44:398\u2013401. https:\/\/doi.org\/10.1097\/00000542-197605000-00008","journal-title":"Anesthesiology"},{"key":"7185_CR45","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41586-024-07587-7","volume":"631","author":"ES O\u2019Brien","year":"2024","unstructured":"O\u2019Brien ES, Rangari VA, El Daibani A et al (2024) A \u00b5-opioid receptor modulator that works cooperatively with naloxone. Nature 631:686\u2013693. https:\/\/doi.org\/10.1038\/s41586-024-07587-7","journal-title":"Nature"},{"key":"7185_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00213-002-1366-x","volume":"167","author":"LV Panlilio","year":"2003","unstructured":"Panlilio LV, Katz JL, Pickens RW, Schindler CW (2003) Variability of drug self-administration in rats. Psychopharmacology 167:9\u201319. https:\/\/doi.org\/10.1007\/s00213-002-1366-x","journal-title":"Psychopharmacology"},{"key":"7185_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/7854_2018_40","volume":"39","author":"JH Porter","year":"2018","unstructured":"Porter JH, Prus AJ, Overton DA (2018) Drug Discrimination: Historical Origins, Important Concepts, and Principles. Curr Top Behav Neurosci 39:3\u201326. https:\/\/doi.org\/10.1007\/7854_2018_40","journal-title":"Curr Top Behav Neurosci"},{"key":"7185_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40262-024-01355-6","volume":"63","author":"TI Saari","year":"2024","unstructured":"Saari TI, Strang J, Dale O (2024) Clinical pharmacokinetics and pharmacodynamics of naloxone. Clin Pharmacokinet 63:397\u2013422. https:\/\/doi.org\/10.1007\/s40262-024-01355-6","journal-title":"Clin Pharmacokinet"},{"key":"7185_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00213-006-0668-9","volume":"191","author":"JD Salamone","year":"2007","unstructured":"Salamone JD, Correa M, Farrar A, Mingote SM (2007) Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191:461\u2013482. https:\/\/doi.org\/10.1007\/s00213-006-0668-9","journal-title":"Psychopharmacology"},{"key":"7185_CR50","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","volume":"171","author":"CL Schmid","year":"2017","unstructured":"Schmid CL, Kennedy NM, Ross NC et al (2017) Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics. Cell 171:1165\u20131175e13. https:\/\/doi.org\/10.1016\/j.cell.2017.10.035","journal-title":"Cell"},{"key":"7185_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drugalcdep.2019.01.022","volume":"198","author":"LP Schwartz","year":"2019","unstructured":"Schwartz LP, Roma PG, Henningfield JE et al (2019) Behavioral economic demand metrics for abuse deterrent and abuse potential quantification. Drug Alcohol Depend 198:13\u201320. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.022","journal-title":"Drug Alcohol Depend"},{"key":"7185_CR52","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","volume":"33","author":"M Shulman","year":"2019","unstructured":"Shulman M, Wai JM, Nunes EV (2019) Buprenorphine Treatment for Opioid Use Disorder: An Overview. CNS Drugs 33:567\u2013580. https:\/\/doi.org\/10.1007\/s40263-019-00637-z","journal-title":"CNS Drugs"},{"key":"7185_CR53","doi-asserted-by":"publisher","first-page":"21422","DOI":"10.1038\/s41598-022-24740-2","volume":"12","author":"LM Slosky","year":"2022","unstructured":"Slosky LM, Pires A, Bai Y et al (2022) Establishment of multi-stage intravenous self-administration paradigms in mice. Sci Rep 12:21422. https:\/\/doi.org\/10.1038\/s41598-022-24740-2","journal-title":"Sci Rep"},{"key":"7185_CR54","unstructured":"Substance Abuse and Mental Health Services Administration (US) (2018) Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, Patients, and Families: Updated 2021. Substance Abuse and Mental Health Services Administration (US). Rockville (MD)"},{"key":"7185_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","volume":"171","author":"J Suzuki","year":"2017","unstructured":"Suzuki J, El-Haddad S (2017) A review: Fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend 171:107\u2013116. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.11.033","journal-title":"Drug Alcohol Depend"},{"key":"7185_CR56","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.15585\/mmwr.mm7348a2","volume":"73","author":"LJ Tanz","year":"2024","unstructured":"Tanz LJ (2024) Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths \u2014 United States, 2021\u20132024. MMWR Morb Mortal Wkly Rep 73:1099\u20131105. https:\/\/doi.org\/10.15585\/mmwr.mm7348a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"7185_CR57","unstructured":"UNODC (2023) Online World Drug Report 2023 - Latest data and trend analysis. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr-2023-online-segment.html. Accessed 20 Mar 2024"},{"key":"7185_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4155\/fmc.13.215","volume":"6","author":"RS Vardanyan","year":"2014","unstructured":"Vardanyan RS, Hruby VJ (2014) Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications. Future Med Chem 6:385\u2013412. https:\/\/doi.org\/10.4155\/fmc.13.215","journal-title":"Future Med Chem"},{"key":"7185_CR59","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O et al (2020) Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Netw Open 3:e1920622. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20622","journal-title":"JAMA Netw Open"},{"key":"7185_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13265","author":"J Wei","year":"2023","unstructured":"Wei J, Lai M, Li F et al (2023) Assessment of abuse potential of carfentanil. Addict Biol. https:\/\/doi.org\/10.1111\/adb.13265","journal-title":"Addict Biol"},{"key":"7185_CR61","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/npp.2013.261","volume":"39","author":"RA Wise","year":"2014","unstructured":"Wise RA, Koob GF (2014) The development and maintenance of drug addiction. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 39:254\u2013262. https:\/\/doi.org\/10.1038\/npp.2013.261","journal-title":"Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol"},{"key":"7185_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00213-017-4739-x","volume":"235","author":"C Zanettini","year":"2018","unstructured":"Zanettini C, Wilkinson DS, Katz JL (2018) Behavioral economic analysis of the effects of N-substituted benztropine analogs on cocaine self-administration in rats. Psychopharmacology 235:47\u201358. https:\/\/doi.org\/10.1007\/s00213-017-4739-x","journal-title":"Psychopharmacology"},{"key":"7185_CR64","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/bs.pbr.2015.09.001","volume":"223","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Leri F (2016) Neuroscience of opiates for addiction medicine: From stress-responsive systems to behavior. Prog Brain Res 223:237\u2013251. https:\/\/doi.org\/10.1016\/bs.pbr.2015.09.001","journal-title":"Prog Brain Res"},{"key":"7185_CR63","doi-asserted-by":"publisher","first-page":"1088498","DOI":"10.3389\/fgene.2023.1088498","volume":"14","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Hong Q, Xu W et al (2023) Differential expression profiling of tRNA-Derived small RNAs and their potential roles in methamphetamine self-administered rats. Front Genet 14:1088498. https:\/\/doi.org\/10.3389\/fgene.2023.1088498","journal-title":"Front Genet"},{"key":"7185_CR65","doi-asserted-by":"publisher","first-page":"e163266","DOI":"10.1172\/JCI163266","volume":"133","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Wang K, Ma T et al (2023) Nucleus accumbens D1\/D2 circuits control opioid withdrawal symptoms in mice. J Clin Invest 133:e163266. https:\/\/doi.org\/10.1172\/JCI163266","journal-title":"J Clin Invest"},{"key":"7185_CR66","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","volume":"185","author":"Y Zhuang","year":"2022","unstructured":"Zhuang Y, Wang Y, He B et al (2022) Molecular recognition of morphine and fentanyl by the human \u00b5-opioid receptor. Cell 185:4361\u20134375e19. https:\/\/doi.org\/10.1016\/j.cell.2022.09.041","journal-title":"Cell"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07185-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07185-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07185-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:07:52Z","timestamp":1792022872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07185-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":67,"alternative-id":["7185"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07185-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"27 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal use protocol described in this study was rigorously reviewed and approved by the Laboratory Animal Welfare and Ethics Committee of the Key Laboratory of Drug Monitoring and Control (ethics approval number: KLDMC-WECLA-202406-03). All husbandry and studies followed methods approved by the Animal Care and Use Committee of the China Pharmaceutical University to ensure full compliance with the 3R principles (replacement, reduction, and refinement) and humane endpoint criteria.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}